https://fccid.io/XGB-2790RX
ADMA BioCenters Received FDA Approval for Sixth Plasma Collection Center, Located in Myrtle Beach, SC
ADMA Biologics, Inc. (NASDAQ: ADMA) ("ADMA"), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics, today announced that it has received U.S.